HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shrikant Anant Selected Research

Hematologic Neoplasms (Hematological Malignancy)

1/2021Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex.
1/2019Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment of Urothelial Cancers, in Rats and Dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shrikant Anant Research Topics

Disease

75Neoplasms (Cancer)
01/2024 - 01/2002
22Colonic Neoplasms (Colon Cancer)
01/2021 - 05/2002
16Pancreatic Neoplasms (Pancreatic Cancer)
01/2024 - 08/2010
12Carcinogenesis
01/2023 - 05/2002
10Colorectal Neoplasms (Colorectal Cancer)
11/2016 - 01/2006
7Adenocarcinoma
01/2024 - 12/2003
7Colitis
12/2021 - 01/2008
6Squamous Cell Carcinoma of Head and Neck
04/2024 - 12/2017
5Melanoma (Melanoma, Malignant)
01/2018 - 07/2010
5Inflammation (Inflammations)
01/2013 - 08/2006
4Infections
01/2020 - 09/2009
4Hyperplasia
03/2019 - 09/2012
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2021 - 08/2006
3Breast Neoplasms (Breast Cancer)
10/2021 - 12/2003
3Adenoma (Adenomas)
01/2021 - 03/2008
3Urinary Bladder Neoplasms (Bladder Cancer)
01/2021 - 01/2019
3Neoplasm Metastasis (Metastasis)
06/2019 - 10/2016
3Radiation Injuries (Radiation Sickness)
12/2004 - 03/2003
2Ovarian Neoplasms (Ovarian Cancer)
04/2023 - 02/2007
2Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 01/2019
2Non-Muscle Invasive Bladder Neoplasms
01/2021 - 01/2020
2Necrosis
01/2020 - 12/2008
2Bacterial Infections (Bacterial Infection)
01/2013 - 09/2012
2Crohn Disease (Crohn's Disease)
01/2008 - 12/2005
1Lymphatic Metastasis
01/2023
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2023
1Papilloma (Papillomatosis)
01/2023

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
04/2024 - 01/2006
8CurcuminIBA
03/2023 - 02/2007
8Messenger RNA (mRNA)IBA
01/2023 - 01/2002
8RNA-Binding Proteins (RNA-Binding Protein)IBA
11/2016 - 01/2003
7Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2021 - 09/2011
7honokiolIBA
01/2021 - 11/2011
7CateninsIBA
01/2021 - 09/2012
6Small Interfering RNA (siRNA)IBA
01/2023 - 05/2008
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 03/2010
5PhytochemicalsIBA
01/2021 - 05/2010
5MicroRNAs (MicroRNA)IBA
06/2015 - 08/2009
4DNA (Deoxyribonucleic Acid)IBA
01/2023 - 12/2006
4LigandsIBA
10/2021 - 11/2011
4DiarylheptanoidsIBA
01/2021 - 08/2010
4Biomarkers (Surrogate Marker)IBA
01/2019 - 12/2008
4CytokinesIBA
04/2014 - 12/2007
4Caspase 3 (Caspase-3)IBA
11/2011 - 03/2008
4Dinoprostone (PGE2)FDA Link
05/2008 - 03/2003
4Prostaglandins EIBA
05/2008 - 12/2003
33,5- bis(2,4- difluorobenzylidene)- 4- piperidoneIBA
01/2023 - 11/2011
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2019
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2021 - 12/2003
3CaspasesIBA
01/2019 - 03/2008
3Cisplatin (Platino)FDA LinkGeneric
12/2017 - 02/2007
3Jagged-1 ProteinIBA
04/2014 - 11/2011
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2008 - 12/2005
3APOBEC-1 DeaminaseIBA
10/2004 - 01/2002
2Doublecortin-Like KinasesIBA
04/2024 - 01/2023
2Matrix Metalloproteinases (MMPs)IBA
04/2024 - 01/2018
2Transcription Factors (Transcription Factor)IBA
01/2023 - 03/2011
2AdipoRonIBA
02/2022 - 01/2022
2Adiponectin ReceptorsIBA
02/2022 - 01/2022
2Prolactin Receptors (Prolactin Receptor)IBA
01/2022 - 01/2020
2Antipsychotic Agents (Antipsychotics)IBA
01/2022 - 01/2020
2Penfluridol (Semap)IBA
01/2022 - 01/2020
2Hormones (Hormone)IBA
01/2022 - 01/2020
2Protein Isoforms (Isoforms)IBA
08/2021 - 06/2021
2RNA (Ribonucleic Acid)IBA
01/2021 - 02/2003
2Antifungal AgentsIBA
01/2021 - 01/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 01/2018
2Ciclopirox (Loprox)FDA LinkGeneric
01/2021 - 01/2019
2PiperidonesIBA
01/2021 - 01/2018
2dibenzazepineIBA
01/2020 - 09/2012
2Dextrans (Dextran)FDA Link
01/2020 - 05/2012
2ProlactinIBA
01/2020 - 04/2014
2sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2020 - 05/2012
2AzoxymethaneIBA
01/2020 - 12/2006
2Histone DemethylasesIBA
12/2019 - 12/2014
2Phosphotransferases (Kinase)IBA
12/2019 - 08/2009
2Hexosaminidases (Hexosaminidase)IBA
01/2019 - 03/2008
2Interleukin-6 (Interleukin 6)IBA
12/2017 - 12/2012
2AntioxidantsIBA
02/2016 - 04/2012
2TOR Serine-Threonine KinasesIBA
12/2014 - 12/2012
2Histones (Histone)IBA
12/2014 - 05/2008
2Drinking WaterIBA
05/2012 - 01/2008
24- (3,5- bis(2- chlorobenzylidene)- 4- oxopiperidine- 1- yl)- 4- oxo- 2- butenoic acidIBA
04/2012 - 08/2010
2Antineoplastic Agents (Antineoplastics)IBA
01/2012 - 03/2008
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2012 - 08/2006
22'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2012 - 09/2011
2Bile Acids and Salts (Bile Acids)IBA
01/2009 - 11/2007
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2008 - 03/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2008 - 12/2007
2sargramostim (Leukine)FDA Link
01/2008 - 08/2006
2EnzymesIBA
12/2003 - 04/2003
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2023
1LeptinIBA
01/2022

Therapy/Procedure

25Therapeutics
04/2024 - 09/2004
8Drug Therapy (Chemotherapy)
04/2021 - 06/2009
6Chemoprevention
06/2019 - 12/2012
5Radiotherapy
12/2020 - 01/2012
2Injections
01/2020 - 12/2019
2Complementary Therapies (Alternative Medicine)
02/2013 - 01/2012